Literature DB >> 9445162

Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles.

Y Birnbaum1, H Luo, T Nagai, M C Fishbein, T M Peterson, S Li, D Kricsfeld, T R Porter, R J Siegel.   

Abstract

BACKGROUND: Previous in vivo studies have shown that microbubbles not only enhance the effectiveness of thrombolytic agents in the presence of ultrasound but may also augment clot dissolution without thrombolytic drugs. METHODS AND
RESULTS: The objective of this study was to examine the efficacy of arterial clot disruption by a noninvasive, nonlytic approach with intravenous administration of perfluorocarbon-exposed sonicated dextrose albumin (PESDA) and transcutaneous delivery of ultrasound alone. Pairs of iliofemoral arteries in 10 rabbits were randomized to receive transcutaneous ultrasound treatment or no ultrasound treatment after an acute artery thrombotic occlusion and intravenous PESDA infusion. Five arteries from 3 additional rabbits served as controls (ultrasound alone). All 10 iliofemoral arteries treated with PESDA + ultrasound were recanalized by angiography after ultrasound treatment. None of the 10 contralateral arteries treated with PESDA alone and none of the 5 arteries treated with ultrasound alone were patent after 1 hour. D-Dimer levels did not change after intravenous PESDA + ultrasound-mediated reperfusion.
CONCLUSIONS: In vivo arterial clot dissolution can be achieved with intravenous microbubbles and transcutaneous ultrasound delivery alone. This technique has potential for clinical application in patients with acute arterial and venous thrombotic occlusions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445162     DOI: 10.1161/01.cir.97.2.130

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  39 in total

1.  Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs.

Authors:  S Atar; H Luo; Y Birnbaum; T Nagai; R J Siegel
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

Review 2.  [Therapeutic ultrasound of acute cerebral artery occlusion].

Authors:  M Nedelmann; T Gerriets; M Kaps
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

3.  Comparison between maximum radial expansion of ultrasound contrast agents and experimental postexcitation signal results.

Authors:  Daniel A King; William D O'Brien
Journal:  J Acoust Soc Am       Date:  2011-01       Impact factor: 1.840

4.  In vitro and in vivo high-intensity focused ultrasound thrombolysis.

Authors:  Cameron Wright; Kullervo Hynynen; David Goertz
Journal:  Invest Radiol       Date:  2012-04       Impact factor: 6.016

Review 5.  Sonothrombolysis.

Authors:  Kenneth B Bader; Guillaume Bouchoux; Christy K Holland
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

6.  Successful microbubble sonothrombolysis without tissue-type plasminogen activator in a rabbit model of acute ischemic stroke.

Authors:  William C Culp; Rene Flores; Aliza T Brown; John D Lowery; Paula K Roberson; Leah J Hennings; Sean D Woods; Jeff H Hatton; Benjamin C Culp; Robert D Skinner; Michael J Borrelli
Journal:  Stroke       Date:  2011-06-23       Impact factor: 7.914

7.  Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Authors:  Azita Soltani; Wayne M Clark; Douglas R Hansmann
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

Review 8.  [Ultrasound contrast agents. Pharmaceutical drug safety and bioeffects].

Authors:  M Krix; J W Jenne
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

9.  Quantitative analysis of ultrasound contrast agent postexcitation collapse.

Authors:  Daniel A King; William D O'Brien
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2014-07       Impact factor: 2.725

10.  Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis.

Authors:  Shaul Atar; Yoram Neuman; Takashi Miyamoto; Ming Chen; Yochai Birnbaum; Huai Luo; Sergio Kobal; Robert J Siegel
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.